ArticleThe American journal of pathology2017

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.

Jinfen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.